During a microbubble infusion, guided high mechanical index impulses from a diagnostic two dimensional transducer improve microvascular recanalization in acute ST segment elevation myocardial infarction (STEMI). The purpose of this study was to further elucidate the mechanism of improved microvascular flow in normal and hyperlipidemic, atherosclerotic pigs.
Introduction
Microvascular thrombi play a major role in the no-reflow phenomena (1) (2) (3) impulses from a three dimensional transducer achieve a similar result as the two dimensional impulses? This would avoid the requirement that one manually scan the risk area during the application of guided high mechanical index impulses. The purpose of this study was to examine the effects of guided high mechanical index impulses from a 3D transducer on microvascular and epicardial reflow in an established porcine model of acute coronary thrombosis, using non-targeted microbubbles that are similar to commercially available microbubbles, in a setting where the coronary arteries are either normal or atherosclerotic.
Methods

Animal Preparation/Protocol
This study was compliant with the guidelines of the Institutional Animal Care and Use
Committee and the standards in the Guide for the Care and Use of Laboratory Animals.
Animals were pre-anesthetized with an intramuscular mixture of Telazol (4.4mg/kg), ketamine (2.2 mg/kg), and xylazine (2.2 mg/kg), and then intubated. Following this, isoflurane inhaled anesthesia (induction at 4%, maintained at 1.0% to 1.8%) was administered. The percent oxygen mixture was kept at 24% during treatment periods in all pigs. Two femoral artery and venous catheters were placed for hemodynamic monitoring and infusions of microbubbles. An 8F guide catheter was introduced into the left main artery for digital angiograms and for balloon catheter insertion. Heart rate and oxygen saturation were also monitored throughout the entire experiment. Low-dose intravenous dobutamine (1 to 3 µg/kg per minute) was used to maintain systolic arterial pressure >80 mmHg during the study protocol. Lidocaine boluses (40 mg IV Chapter 4 58 followed by 20 mg IV boluses × 3) and a continuous lidocaine infusion (2 to 4 mg/min IV) were used in all animals to control arrhythmias. Acute left anterior descending (LAD) thrombotic occlusions were created in 28 pigs. Two of these pigs died of refractory ventricular fibrillation before treatment could be initiated, leaving a total sample size of 26 pigs. In 12 of the pigs, pre-existing atherosclerotic lesions were created by a balloon injury in the left anterior descending on day zero, following by a high fat diet (15% Lard, 2% Cholesterol; Harlan Laboratories, Madison, WI) lasting 52 ± 21 days.
Coronary artery thrombotic occlusions were created in the 14 normal pigs by simulating the triad of Virchow. (10) This consists of creating endothelial injury, stasis, and a hypercoagulable state. Endothelial injury was created by advancing a balloon catheter into the left anterior descending, after the second diagonal branch, and inflating the balloon for 30 seconds three times at maximum diameters that were 110% of the measured coronary artery diameter. This balloon catheter was then withdrawn proximal to the injury site and partially inflated to reduce flow at the injury site. Then, small 0.1-0.2 milliliters of clotting venous blood from the pig were injected through the balloon catheter into the site of injury to create a hypercoagulable state.
Once angiographic LAD occlusion was documented, it had to persist for at least 20 minutes. If spontaneous recanalization occurred, small thrombus injections were again administered through the balloon catheter until persistent occlusion was observed. Following this, pigs had baseline measurements of heart rate, oxygen saturation, arterial blood pressure, wall thickening, myocardial blood flow (MBF) with radiolabeled neutron-activated microspheres, perfusion defect size at plateau intensity (ultimate infarct size) with contrast low mechanical index imaging, and ST segment elevation on 12 lead EKG. Subsequently, 650 milligrams of aspirin was administered per nasogastric tube, followed by an intravenous heparin bolus (80 mg/kg), and a bolus injection of ½ dose fibrinolytic agents (0.25 mg/kg Tenecteplase or 1mg/kg tissue plasminogen activator (Genetech). The normal pigs were then randomized to receive either no additional treatment (n=7 that composed a control group; subsequently referred to as Group I) or a continuous intravenous infusion of MRX-801 with intermittent high mechanical index impulses applied whenever microbubbles were visualized within the risk area (subsequently referred to as Group II).
In the 12 atherosclerotic pigs, coronary artery thrombi were created at 52 ± 21 days following the day zero balloon injury using the same protocol described for Group I and II pigs. The second balloon injury occurred at the same location as the day zero balloon injury. Specific angiographic markers were used (e.g. location in distance from a diagonal branch) to ensure that the thrombus initiation site on day 50 was at the site of balloon injury at day zero. 
Ultrasound and Microbubble Protocol
The microbubbles used for all studies were a lipid encapsulated formulation (MRX-801; NuvOx Pharma; Tucson, AZ). These microbubbles have a diameter of 1.0±0.1 μm, with concentration of 1.5 to 3.0 × 10 10 /ml. The microbubble infusion for both therapeutic and diagnostic studies were prepared by diluting 2 ml of the MRX-801 in 100 ml of 0.9% saline and infusing at a rate of 2.5-3.0 ml/min.
In pigs randomized to receive ultrasound, a real-time low mechanical index biplane image was 
Myocardial Blood Flow Measurements
In order to determine how guided high mechanical index impulses and microbubbles affect peri-infarct MBF even in the absence of epicardial recanalization, MBF measurements were measured in Group I and II pigs using left atrial injections of neutron activated microspheres (15 micron diameter; Biopal; Worcester, MA) just prior to initiation of treatment, at 25 minutes into treatment, and at 60 minutes following completion of treatment. Following sacrifice, the excised heart was divided into eight subendocardial and sub-epicardial segments ( Figure 2 ). MBF analysis from these eight segments demonstrate that there was a consistent segment Chapter 4 60 with very low flow (corresponding to the central portion of the risk area), and two segments bordering on this central segment which had reduced flow, and hence we defined these as the peri-infarct regions. Peri-infarct MBF was defined as the ratio of averaged myocardial blood flow within the two bordering segments surrounding the segment with lowest blood flow divided by reference MBF within two normal segments in the lateral and inferolateral walls. 
Post Mortem Measurements
After the 90 minute angiograms and final MBF measurements, the pigs were sacrificed. In those pigs treated with high fat diets, the coronary arteries were dissected and analyzed with Hematoxylin/Eosin staining for presence of intra-coronary thrombus, dissection, and percent intimal hyperplasia. 
Outcome Measurements
In all pigs, epicardial recanalization was assessed by angiography using left main coronary artery injections of five milliliters of iodinated contrast at 30, 60, and 90 minutes following initiation of treatment protocols. Assessments of flow in the left anterior descending were visually estimated by a blinded experienced reviewer using the TIMI criteria.(11) Twelve lead EKG's were obtained at baseline prior to treatment, and at 30, 60, and 90 minutes as well.
Maximal ST segment elevation was compared at each time point. One pig in Group II was excluded from the ST segment recovery analysis because it did not exhibit ST deviation in any lead following angiographic occlusion of the LAD. Wall thickening within the central portion of the risk area on a two dimensional short axis view (mid-papillary muscle level) was computed off line by a blinded reviewer, who measured end-diastolic and end-systolic wall thickness prior to treatment, and at sixty minutes into treatment. Percent wall thickening was defined as the difference in thickness measurements divided by end-diastolic wall thickness × 100% (9) . All measurements were made by an independent reviewer blinded to treatment protocol. 
Statistical Comparisons
Group I and II pig results were compared with each other, as were Group III versus Group IV.
Comparisons of angiographic patency rates between the two treatment groups were made with a Chi Square test. Changes in percent wall thickening and ST segment resolution within groups were determined using paired t testing. Changes in peri-infarct radiolabeled MBF ratios, contrast echo-derived defect size at plateau intensity (ultimate infarct size) were also compared within groups using paired-t-testing. Inter-and intra-observer variabilities in perfusion defect size at plateau intensity were computed using a Bland Altman test. Table 1 demonstrates arterial pressure, oxygen saturation, heart rate, left atrial pressures, and activated clotting time measurements at baseline and 90 minutes into treatment. No differences were observed in any of these parameters between Groups I and II, as well as between Groups III and IV. Median duration of thrombotic occlusion prior to treatment was 24 minutes (mean 26 ± 7 minutes), and was not different in the four groups (Table 1 ). In the atherosclerotic pigs, mean fasting cholesterol levels increased from 62 ± 28 mg/dl to 487 ± 216 mg/dl at 52 ± 21 days following initiation of the high cholesterol diet. Table 2 displays the angiographic, EKG, and WT recovery within the risk area following treatment in Groups I and II. Baseline TIMI scores were zero in all pigs prior to treatment.
Results
Hemodynamic and Histological Findings
Angiographic recanalization rates and TIMI 3 flow were the same in the Group I and Group II pigs (2/7, or 29%, in each group) at 60 and 90 minutes into treatment. There were no differences in measured ST segment elevation or WT within the risk area prior to initiation of treatment in Group I and Group II (Table 2) . However, Group II pigs had significant reductions in ST segment elevation already at 30 minutes following initiation of treatment. Wall thickening within the risk area improved only in the Group II pigs. Table 3 displays the same data for the atherosclerotic pigs. Epicardial recanalization and TIMI 3 flow was present in all six Group IV pigs, compared to 3/6 for control Group III atherosclerotic pigs (p=0.09). Similar to Group II pigs, only pigs treated with guided high mechanical index impulses and microbubbles had recovery of ST segments, and improvements in wall thickening. The total duration of high mechanical index exposure did not differ between the normal pigs and atherosclerotic pigs treated with ultrasound (14.8 ± 3.5 minutes for Group I and 13.7 ± 1.5 minutes Group III). 
Myocardial Blood Flow Measurements
Microsphere-derived MBF measurements were obtained in six normal Group I pigs and five Group II pigs. Figure 3a demonstrates the changes in peri-infarct MBF ratios at rest, 30, and 90 minutes into treatment in all Group I and II pigs, while Figure 3b demonstrates the changes in pigs where epicardial recanalization did not occur. There were no differences in the periinfarct MBF ratios at rest. However, at the end of the ultrasound treatment (30 minutes), there was a consistent increase in MBF in the peri-infarct zones in Group II pigs, including those who did not have epicardial recanalization (Figure 3b) . 
Ultimate Infarct Size by Myocardial Contrast Echocardiography
Mean planimetered defect size at the plateau intensity, prior to treatment, was smaller in the Group III and IV pigs (2.7 ± 0.3 cm 2 for Group I, 2.7 ± 0.3 cm 2 for Group II, 1.55 ± 0.36 cm 2 for
Group III, and 1.63 ± 0.52 cm 2 for Group IV; p<0.05; Group III and IV compared to other groups). Both Group II and Group IV pigs had significant decreases in plateau defect size after treatment (p<0.001 for both groups compared to their respective control groups). Defect size, after therapy, was significantly smaller in Group II pigs (2.2 ± 1.3 cm 2 for Group I, 1.6 ± 0.6 cm 2 for Group II; p=0.005). Although perfusion defect sizes prior to treatment were similar in the atherosclerotic pigs, perfusion defect size following treatment was significantly smaller in Group IV pigs (0.53 ± 0.43 cm 2 Group IV versus 1.12 ± 0.37 cm 2 Group IIII; p=0.02). Figure 4 displays an example in the reduction in plateau myocardial contrast defect size at 90 minutes into treatment in a Group I versus a Group II pig. Figure 5 depicts examples of the reduction First, increased lipid levels have been associated with higher endogenous levels of tissue plasminogen activator. (19) In the presence of these higher endogenous lytics, the shearing of the thrombus by cavitation induced by the guided high mechanical index impulses could have increased the exposure of the plasminogen activator to fibrin embedded within the thrombus.
A second potential explanation is that the increased plaque volume within the vessel may have reduced the size of thrombus required to occlude the coronary artery. Thus, less thrombus dissolution may have been required to restore epicardial flow. Thirdly, since the pigs on an atherosclerotic diet were larger than the normal Group I or II pigs after their high cholesterol diet, their weight-adjusted doses of both lytic agents and heparin were higher, which may have improved their efficacy in dissolving the thrombus. This is why a control group that underwent the same atherosclerotic diet and balloon injury protocol was added (Group III) . This group, although receiving higher weight adjusted doses of fibrinolytic agents and heparin, still had only a 50% epicardial recanalization rates and less improvement in microvascular volume (Table 3) . 
Limitations of The Study
We only used a thirty minute ultrasound treatment period in the current study, to match what had been attempted in previous animal studies. To our knowledge, no one has used extended microbubble infusions beyond a 30 minute treatment period in this acute myocardial infarction model. It is possible that longer treatment periods may further improve microvascular outcome.
In the clinical setting, this may be helpful since microvascular emboli would still be expected to occur after primary percutaneous interventions. (21) Further study is needed to explore what effects longer treatment times have on microvascular flow, and how this affects outcome in the setting of primary percutaneous interventions.
Although the three dimensional guided high MI impulses, in the presence of microbubbles, were successful in restoring both microvascular and epicardial blood flow in this study, we did not directly compare our results with what could have been achieved with a two dimensional transducer. Nonetheless, the three dimensional transducer has practical advantages, in that the entire volume of the risk area can be covered during the high MI impulses, without the need to manually move the probe during the high MI applications. Chapter 4 70
Conclusions
The utilization of guided high mechanical index impulses from a 3D transducer improves microvascular flow rates following STEMI in pigs. The improvement in microvascular flow was in the peri-infarct segments, and occurred independent of epicardial recanalization.
Greater reductions in perfusion defect size and epicardial recanalization rates are observed in the setting of hypercholesterolemia and underlying plaque.
This study utilized intravenous non-targeted microbubbles that are very similar to what is already commercially available, and guided 3D high mechanical index impulses from a clinical diagnostic ultrasound system. The three dimensional probe used in this study had a practical advantage in that high mechanical index impulses could be delivered to the entire risk area without probe manipulation.
It has been shown that 65% of patients treated with state-of-the-art percutaneous coronary interventions in acute STEMI have persistent microvascular obstruction (21) . Our study shows this microvascular obstruction could be reduced significantly with the addition of guided high mechanical index impulses and intravenous microbubbles, thus preventing the adverse remodeling that leads to reductions in left ventricular ejection fraction and development of congestive heart failure. This safe and effective therapy, therefore, could not only prevent significant complications in patients with STEMI, but also reduce the enormous costs associated with these complications.
